Yesterday, the Trump Administration issued an Executive Order titled “Increasing Medical Marijuana and Cannabidiol Research” (the “EO”). It directs the Attorney General to expedite the rulemaking process related to rescheduling marijuana to Schedule III of the Controlled Substances Act, representing a significant step forward in recognizing the medical benefit of cannabis.
| less than a minute read
President Trump’s Executive Order on Marijuana Rescheduling also Directs HHS to Develop Models to Improve Access to Hemp-Derived Cannabinoid Products
Latest Insights
/Passle/MediaLibrary/Images/2025-09-22-10-49-33-834-68d129bd4212553ec5d66b3a.jpg)
/Passle/MediaLibrary/Images/2025-09-22-10-35-40-566-68d1267cdf36028526d6a53e.jpg)
/Passle/MediaLibrary/Images/2025-09-22-10-35-41-071-68d1267d4212553ec5d659f8.jpg)
/Passle/MediaLibrary/Images/2025-09-22-10-35-41-244-68d1267d4212553ec5d65a14.jpg)